Carisma Therapeutics Inc. (CARM)
NASDAQ: CARM
· Real-Time Price · USD
0.45
-0.05 (-10.41%)
At close: Jun 20, 2025, 3:59 PM
Carisma Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -50.77M | -60.48M | -63.8M | -72.5M | -81.22M | -86.88M | -73.5M | -70.42M | -65.39M | -52.06M | -35.54M | 54.41M | 43.81M | -388K | -24.34M | -118.57M | -119.47M |
Depreciation & Amortization | 2.32M | 3.35M | 4.77M | 4.73M | 5.19M | 4.2M | 2.82M | 2.85M | 2.38M | 1.89M | 1.2M | 484K | 273K | 85K | 104K | 125K | 121K |
Stock-Based Compensation | 3.1M | 3.65M | 3.67M | 3.4M | 3.11M | 2.32M | 1.48M | 723K | 451K | 275K | 353K | 367K | 438.5K | 479K | 767K | 1.12M | 1.48M |
Other Working Capital | -4.07M | -10.1M | -17.46M | -16.77M | -6.4M | -7.63M | -11.97M | -9.07M | -11.31M | 17.33M | 27.13M | 17.25M | 5.62M | -23.89M | -30.77M | -22.21M | -11.16M |
Other Non-Cash Items | 5.05M | 6.72M | 9.85M | 10.32M | 7.37M | 8.28M | -8.67M | -7.97M | -7.34M | -8.29M | 27.39M | -59.69M | -46.58M | 4.97M | -11.01M | 92.32M | 95.68M |
Deferred Income Tax | n/a | n/a | -3.22M | -3.39M | -3.8M | -3.8M | 12.87M | 13.71M | 14.11M | 14.11M | 668K | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -4.09M | -11.95M | -17.87M | -17.14M | -8.86M | -5.44M | 2.6M | 11.38M | 10.31M | 58.74M | 29.9M | 18.3M | 7.47M | -48.63M | -29.49M | -24.56M | -14.11M |
Operating Cash Flow | -47.56M | -59.92M | -67.81M | -75.79M | -78.21M | -81.32M | -62.4M | -49.72M | -45.47M | 14.66M | -616K | -6.96M | -15.8M | -68.88M | -64.79M | -54.13M | -40.47M |
Capital Expenditures | -94K | -111K | -672K | -873K | -1.01M | -1.13M | -890K | -3M | -3.79M | -4.66M | -4.69M | -2.34M | -1.36M | -849.5K | -512.5K | -557.5K | -508.5K |
Cash Acquisitions | n/a | n/a | -3.46M | -3.46M | -3.46M | n/a | -10.35M | -52.35M | -52.35M | -55.81M | -42M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | 49.7M | 49.7M | 49.7M | n/a | n/a | -34.46M | -49.7M | -91.62M | -70.48M | -99.26M | -84.03M | -42.1M | -63.24M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | -20.07M | 41M | 77M | 108M | 172M | 184M | 148M | 117M | 42M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -74.4M | -74.92M | -63.92M | 41M | 77M | 73.54M | 76.67M | 88.67M | 73.81M | 14.03M | -103K | -42.1M | -63.29M | -49K | -41K | -41K | n/a |
Investing Cash Flow | 418K | -123K | -45.98M | 40.13M | 75.99M | 72.41M | 121.73M | 89.69M | 74.05M | 13.39M | -46.71M | -44.44M | -64.6M | -849.5K | -512.5K | -557.5K | -516.5K |
Debt Repayment | -110K | -1.43M | -1.16M | -1.84M | -2.36M | -1.15M | -1.15M | -962K | -872K | 34.23M | 34.23M | 34.98M | 35M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1M | 1.67M | 2.09M | 1.33M | -1.85M | 32.69M | 32.59M | 34.23M | 37.75M | 544K | 543K | n/a | 64.26M | 137.31M | 159.24M | 167.47M | 103.21M |
Financial Cash Flow | -1.63M | 344K | 1.21M | -361K | -4.06M | 62.33M | 62.08M | 63.91M | 67.52M | 34.78M | 34.78M | 73.8M | 138.08M | 176.13M | 198.06M | 167.47M | 107.98M |
Net Cash Flow | -48.77M | -59.7M | -56.25M | -35.99M | -6.26M | 53.44M | 121.41M | 103.88M | 96.1M | 62.84M | -12.21M | 125.6M | 160.85M | 210.06M | 236.08M | 113.25M | 67.48M |
Free Cash Flow | -47.66M | -60.04M | -68.49M | -76.66M | -79.23M | -82.45M | -63.29M | -52.72M | -49.26M | 10.01M | -5.3M | -9.3M | -17.16M | -69.73M | -65.3M | -54.68M | -40.98M |